Company intelligence / Profile preview

terraplasma

Garching (near Munich), Bavaria, Germany

Ownership: Private
Employees: ~8
Development stage: Other

Overview

terraplasma medical has developed and CE-marked the plasma care product line, portable cold atmospheric plasma devices used clinically for antimicrobial treatment and wound healing, supported by extensive preclinical safety/efficacy studies and ongoing multicenter clinical and post‑market follow‑up trials in infected chronic wounds.[3][4][5][7][1]

Therapeutic areas: DermatologyInfectious Diseases
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Partnerships

BioLab Holdings (strategic investment and commercialization partnership for plasmapax device and U.S. market access)[1]

Beyond the preview

Go deeper on terraplasma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on terraplasma.

Explore the full profile